Bridging the gaps in drug discovery

<p><span data-contrast="auto">In the</span><a href= "https://www.ddw-online.com/t/in-conversation-series/"><em><span data-contrast="auto"> In Conversation With</span></em> </a><span data-contrast= "auto">series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. </span> <span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p style="font-weight: 400;"><span data-contrast="auto">In this latest episode, DDW's Megan Thomas is</span> in conversation with Dr Martin Main, Chief Scientific Officer at Medicines Discovery Catapult (MDC), and Dr Nicola Heron, Chief Strategy Officer at MDC.</p> <p><span data-contrast="auto">MDC is part of the Catapult Network established by Innovate UK and has a vision to reshape drug discovery for the benefit of patients by transforming great UK science into better treatments through partnership. Dr Main and Dr Heron share what MDC is doing to bridge the gaps in drug discovery. </span><span data-ccp-props="{}"> </span></p>